Interasma Global Asthma Association

All posts by interasm_wp

The following new article have just been published in Asthma Research and Practice: Exhaled biomarkers in childhood asthma: old and new approaches

Review – Open Access   Valentina Ferraro, Silvia Carraro, Sara Bozzetto, Stefania Zanconato and Eugenio Baraldi   Asthma Research and Practice 2018 4:9 Abstract Background Asthma is a chronic condition usually characterized by underlying inflammation. The study of asthmatic inflammation is…

Asthma-like symptoms: is it always a pulmonary issue?

Multidisciplinary Respiratory Medicine Case report – Open Access Davide Piloni, Claudio Tirelli, Rita Di Domenica, Valentina Conio, Amelia Grosso, Vanessa Ronzoni, Filippo Antonacci, Pasquale Totaro and Angelo G. Corsico Multidisciplinary Respiratory Medicine 2018 13:21 Abstract Background Double aortic arch is a rare congenital and complete vascular ring around trachea and esophagus.…

Agreement in reporting of asthma by parents or offspring – the RHINESSA generation study

Research article,Open Access, Open Peer Review Ingrid N. Kuiper, Cecilie Svanes, Bryndis Benediktsdottir, Randi J. Bertelsen, Lennart Bråbäck, Shyamali C. Dharmage, Mathias Holm, Christer Janson, Rain Jögi, Andrei Malinovschi, Melanie Matheson, Jesús Martínez Moratalla, Francisco Gómez Real, José Luis Sánchez-Ramos, Vivi Schlünssen, Signe Timm and Ane Johannessen BMC Pulmonary Medicine 2018 18:122 Open Peer Review reports Abstract Background Self-report questionnaires are commonly used in epidemiology, but may be susceptible to misclassification,…

Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: A cross-over randomised controlled trial

Respiratory Research Open Access George Bardsley, Peter DaleyYates, Amanda Baines, Rodger Kempsford, Mathew Williams, Tony Mallon, Irene Braithwaite, Kylie Riddell, Shashidhar Joshi, Philippe Bareille, Richard Beasley, James Fingleton on behalf of the study team   Respiratory Research 2018 19:133 Abstract Background Fluticasone furoate/Vilanterol trifenatate (FF/VI) is an inhaled corticosteroid/long-acting beta-agonist combination with a prolonged bronchodilator duration…

Do airway inflammation and airway responsiveness markers at the start of apprenticeship predict their evolution during initial training? A longitudinal study among apprentice bakers, pastry makers and hairdressers

BMC Pulmonary Medicine Research article – Open Access – Open Peer Review Valérie Demange, Denis Zmirou-Navier, Abraham Bohadana and Pascal Wild BMC Pulmonary Medicine 2018 18:113 Open Peer Review reports Abstract Background The natural history of airway inflammation and symptoms…

Cell distribution and cytokine levels in induced sputum from healthy subjects and patients with asthma after using different nebulizer techniques

Research article, Open Access, Open Peer Review Sinem Koc-Günel, Ralf Schubert, Stefan Zielen and Martin Rosewich BMC Pulmonary Medicine 2018 18:115 Open Peer Review reports Abstract Background Sputum induction is an important noninvasive method for analyzing bronchial inflammation in…

Assessment of predictors for acute asthma attack in asthmatic patients visiting an Ethiopian hospital: are the potential factors still a threat?

Research – Open Access Sewunet Admasu Belachew Daniel Asfaw Erku, Dawit Kumilachew Yimenu and Begashaw Melaku Gebresillassie Asthma Research and Practice 201 84:8 https://doi.org/10.1186/s40733-018-0044-7 Abstract Background Recurrent exacerbations in patients with moderate or severe asthma are the major causes of morbidity, mortality…

Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study

Marc Humbert, Camille Taillé, Laurence Mala, Vincent Le Gros, Jocelyne Just, Mathieu Molimard European Respiratory Journal 2018 51: 1702523; DOI: 10.1183/13993003.02523-2017 Abstract Omalizumab is a monoclonal anti-IgE antibody used to treat severe allergic asthma (SAA). The aim of the STELLAIR study was to determine the importance…